Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rockwell Medical IN (RMTI)

Rockwell Medical IN (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 174,998
  • Shares Outstanding, K 57,565
  • Annual Sales, $ 63,390 K
  • Annual Income, $ -32,130 K
  • 60-Month Beta 1.47
  • Price/Sales 2.72
  • Price/Cash Flow N/A
  • Price/Book 8.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.11
  • Low Estimate -0.19
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.85 +3.86%
on 07/02/19
4.53 -34.66%
on 06/17/19
-1.22 (-29.19%)
since 06/14/19
3-Month
2.85 +3.86%
on 07/02/19
5.80 -48.98%
on 05/10/19
-2.02 (-40.56%)
since 04/15/19
52-Week
2.19 +35.16%
on 12/31/18
6.88 -56.98%
on 03/21/19
-1.31 (-30.68%)
since 07/13/18

Most Recent Stories

More News
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals and Intuit and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Rockwell Medical, Inc., Amneal Pharmaceuticals, Inc., and Intuit, Inc. Additional information about...

INTU : 282.55 (+0.32%)
RMTI : 2.96 (-2.63%)
AMRX : 3.51 (-5.14%)
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Acadia Healthcare, Fluor Corporation, and Rockwell Medical on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of the following companies:

ACHC : 33.34 (-0.51%)
RMTI : 2.96 (-2.63%)
FLR : 33.12 (+0.73%)
Rockwell Medical (RMTI) Reports Q1 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 16.67% and -7.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RMTI : 2.96 (-2.63%)
Rockwell Medical: 1Q Earnings Snapshot

WIXOM, Mich. (AP) _ Rockwell Medical Inc. (RMTI) on Thursday reported a loss of $8.7 million in its first quarter.

RMTI : 2.96 (-2.63%)
Rockwell Medical, Inc. Reports First Quarter 2019 Financial Results

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal...

RMTI : 2.96 (-2.63%)
Biotech Stocks: Global Revenues for Ophthalmology Market Projected to Reach $26 Billion by 2022

As the baby boomer generation ages, there is an increased need no a demand by these aging patients to avert vision and blindness problems that come with aging. An industry report GBI Research stated that...

PTCT : 43.62 (+1.54%)
GHSI : 0.94 (-4.95%)
RMTI : 2.96 (-2.63%)
BSGM : 8.45 (-1.29%)
VRAY : 9.35 (+1.96%)
Shares of Rockwell Medical Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (RMTI , PODD , NUVA , IVC , INGN )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

NUVA : 57.48 (+0.72%)
RMTI : 2.96 (-2.63%)
PODD : 120.70 (+0.37%)
Rockwell Medical, Inc. Commences Commercial Sales of Dialysate Triferic(R) in the U.S.

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a global biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage...

RMTI : 2.96 (-2.63%)
Rockwell Medical, Inc. to Discuss First Quarter 2019 Financial Results on May 9, 2019

Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter financial results on Thursday, May 9, 2019, after the closing...

RMTI : 2.96 (-2.63%)
CMS Issues Preliminary Recommendation to Establish a New J-Code for Triferic(R) Powder Packet

Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company"), a global biopharmaceutical company dedicated to improving outcomes for patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD),...

RMTI : 2.96 (-2.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade RMTI with:

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

2nd Resistance Point 3.15
1st Resistance Point 3.05
Last Price 2.96
1st Support Level 2.90
2nd Support Level 2.85

See More

52-Week High 6.88
Fibonacci 61.8% 5.09
Fibonacci 50% 4.53
Fibonacci 38.2% 3.98
Last Price 2.96
52-Week Low 2.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar